4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001209191-23-016774
President and CEO acquired 9,582 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| White Marvin L President and CEO | 2023-03-03 | Option exercise | +9,582 | 40,137 | D | ||
| Derivatives | |||||||
| White Marvin L President and CEO | 2023-03-03 | Option exercise · Restricted Stock Unit | −9,582 | 19,168 | D | ||
| White Marvin L President and CEO | 2023-03-03 | Grant or award · Restricted Stock Unit | +38,750 | 38,750 | D | ||
| White Marvin L President and CEO | 2023-03-03 | Grant or award · Stock Option (right to buy) | +38,750 | 38,750 | D | ||
Loading xslF345X03/doc4.xml…